Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Biochem Biophys Res Commun ; 527(3): 785-790, 2020 06 30.
Article in English | MEDLINE | ID: mdl-32423826

ABSTRACT

Diabetic neuropathic pain is one of the most common complications of diabetes. Mechanisms underlying the central modulation are still unclear. Here, we investigated the role of the neuron-restricted silencing factor (NRSF/REST) in diabetic-related neuropathic pain. Mechanical allodynia and thermal hyperalgesia were assessed to evaluate painful behaviors. Our results found that in the anterior cingulate cortex (ACC) of db/db mice, NRSF/REST levels increased significantly. Reduction of NRSF/REST improved the painful sensation. Meanwhile, in vitro study found that high glucose and high palmitic acid treatment induced elevation of NRSF/REST and its cofactors (mSin3A, CoREST and HDAC1), whereas downregulation of GluR2 and NMDAR2B. Knockdown of NRSF/REST could attenuate the LDH release and partially reversed the expression changes of HDAC1 and NMDAR2B. Our results suggested that the elevation of NRSF/REST in the ACC area of db/db mice is one of the key mediators of diabetic neuropathic pain.


Subject(s)
Diabetic Neuropathies/physiopathology , Gyrus Cinguli/physiopathology , Hyperalgesia/physiopathology , Repressor Proteins/metabolism , Animals , Diabetic Neuropathies/complications , Diabetic Neuropathies/genetics , Diabetic Neuropathies/metabolism , Gene Knockdown Techniques , Gyrus Cinguli/metabolism , Hyperalgesia/complications , Hyperalgesia/genetics , Hyperalgesia/metabolism , Male , Mice , PC12 Cells , Rats , Repressor Proteins/genetics , Up-Regulation
SELECTION OF CITATIONS
SEARCH DETAIL
...